NCT06460922 3D Printing Models in Surgical Planning of Osteotomies in Kienbock´s Disease Stages II-III
| NCT ID | NCT06460922 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau |
| Condition | Kienbock Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 20 participants |
| Start Date | 2024-05-10 |
| Primary Completion | 2026-11-28 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 20 participants in total. It began in 2024-05-10 with a primary completion date of 2026-11-28.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Ischemic necrosis of lunate bone, osteonecrosis or Kienböck´s disease was described by Kienböck in 1910. Numerous surgical procedures for this disease had been proposed. These surgical options, that depends of the radiological stage and anatomical risk factors, can be classified into lunate unloading procedures, lunate revascularization, replacement procedures and salvage procedures. These procedures, except the salvage procedures, has been successful in reconstructing and maintaining the height of the carpus, avoiding progression of the disease and with reduction of the pain. The lunate unloading procedures are surgical treatments that make a radial osteotomy for modify differents anatomical risk factors associated with the osteonecrosis.
Eligibility Criteria
Inclusion Criteria: * Kienbock´s disease in the wrist estages II, IIIA, IIIB or IIIC by Lichtman classification Exclusion Criteria: * Pre-radiological stages-Lichtman stage I * Radiocarpal and midcarpal osteoarthrosis, Lichtman stage IV * Kienböck in children: less than 18 years * Adults years greater than 85 years old
Contact & Investigator
Claudia Lamas, MD, Ph D
PRINCIPAL INVESTIGATOR
Research Institute IIB Sant Pau. Institut de Recerca de l´Hospital de la Santa Creu i Sant Pau
Frequently Asked Questions
Who can join the NCT06460922 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 85 Years, studying Kienbock Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06460922 currently recruiting?
Yes, NCT06460922 is actively recruiting participants. Contact the research team at clamasg@santpau.cat for enrollment information.
Where is the NCT06460922 trial being conducted?
This trial is being conducted at Barcelona, Spain.
Who is sponsoring the NCT06460922 clinical trial?
NCT06460922 is sponsored by Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau. The principal investigator is Claudia Lamas, MD, Ph D at Research Institute IIB Sant Pau. Institut de Recerca de l´Hospital de la Santa Creu i Sant Pau. The trial plans to enroll 20 participants.